Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections

Sustained Elevation in Intraocular Pressure Associated with Intravitreal Bevacizumab Injections

(2009) Malik Y. Kahook et al.   OPHTHALMIC SURGERY LASERS & IMAGING

A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations

(2008) Peep V. Algvere et al.   ACTA OPHTHALMOLOGICA

Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti–Vascular Endothelial Growth Factor Agents

(2008) Judy E. Kim et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration

(2008) G Mojica et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial

(2008) L J Singerman et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Persisent ocular hypertension following intravitreal ranibizumab

(2008) Sophie J. Bakri et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY